These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28358738)

  • 1. α7-Nicotinic acetylcholine receptor inhibition by indinavir: implications for cognitive dysfunction in treated HIV disease.
    Ekins S; Mathews P; Saito EK; Diaz N; Naylor D; Chung J; McMurtray AM
    AIDS; 2017 May; 31(8):1083-1089. PubMed ID: 28358738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular binding of indinavir to matrix metalloproteinase-2 and the alpha-7-nicotinic acetylcholine receptor: implications for use in cancer treatment.
    Lee A; Saito E; Ekins S; McMurtray A
    Heliyon; 2019 Sep; 5(9):e02526. PubMed ID: 31687607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance of indinavir by dose adjustment in HIV-1-infected patients with indinavir-related toxicity.
    Wasmuth JC; Lambertz I; Voigt E; Vogel M; Hoffmann C; Burger D; Rockstroh JK
    Eur J Clin Pharmacol; 2007 Oct; 63(10):901-8. PubMed ID: 17690876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional properties of alpha7 nicotinic acetylcholine receptors co-expressed with RIC-3 in a stable recombinant CHO-K1 cell line.
    Roncarati R; Seredenina T; Jow B; Jow F; Papini S; Kramer A; Bothmann H; Dunlop J; Terstappen GC
    Assay Drug Dev Technol; 2008 Apr; 6(2):181-93. PubMed ID: 18471073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of nicotinic acetylcholine alpha7 receptors rescue schizophrenia-like cognitive impairments in rats.
    Potasiewicz A; Nikiforuk A; Hołuj M; Popik P
    J Psychopharmacol; 2017 Feb; 31(2):260-271. PubMed ID: 28168926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in HIV patients switching to twice-daily indinavir/ritonavir regimen or continuing with three-times-daily indinavir-based therapy.
    Badía X; Podzamczer D; Moral I; Roset M; Arnaiz JA; Loncà M; Casiró A; Rosón B; Gatell JM;
    Antivir Ther; 2004 Dec; 9(6):979-85. PubMed ID: 15651756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe impairment of endothelial function with the HIV-1 protease inhibitor indinavir is not mediated by insulin resistance in healthy subjects.
    Dubé MP; Gorski JC; Shen C
    Cardiovasc Toxicol; 2008 Mar; 8(1):15-22. PubMed ID: 18172783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GTS-21 attenuates lipopolysaccharide-induced inflammatory cytokine production in vitro by modulating the Akt and NF-κB signaling pathway through the α7 nicotinic acetylcholine receptor.
    Yue Y; Liu R; Cheng W; Hu Y; Li J; Pan X; Peng J; Zhang P
    Int Immunopharmacol; 2015 Dec; 29(2):504-512. PubMed ID: 26490221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indinavir (Crixivan).
    Res Initiat Treat Action; 2000 Mar; 6(1):28-9. PubMed ID: 11708184
    [No Abstract]   [Full Text] [Related]  

  • 10. Indinavir urinary stones as origin of upper urinary tract obstruction.
    John H; Müller NJ; Opravil M; Hauri D
    Urol Int; 1997; 59(4):257-9. PubMed ID: 9444746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indinavir: lightening the load.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1996 Aug; 2(8):6-11. PubMed ID: 11363759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary calculi and indinavir sulfate in patients with HIV infection. Apropos of 4 cases].
    Chefchaouni MC; Thiounn N; Flam T; Zerbib M; Debré B
    J Urol (Paris); 1997; 103(1-2):35-6. PubMed ID: 9765778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The choice of HIV protease inhibitor: indinavir is currently the best option.
    Prescrire Int; 1999 Apr; 8(40):55-60. PubMed ID: 10848067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of zacopride and new quaternarized fluorobenzamide analogues on mammalian α7 nicotinic acetylcholine receptor.
    Bourdin CM; Lebreton J; Mathé-Allainmat M; Thany SH
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3184-8. PubMed ID: 26087938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urolithiasis and the protease inhibitor indinavir.
    Hermieu J; Prévot M; Ravery V; Sauty L; Moulinier F; Delmas V; Bouvet E; Boccon-Gibod L
    Eur Urol; 1999; 35(3):239-41. PubMed ID: 10072627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of inhibitory and excitatory effects of α7 nicotinic acetylcholine receptor activation in the prelimbic cortex regulates network activity and plasticity.
    Udakis M; Wright VL; Wonnacott S; Bailey CP
    Neuropharmacology; 2016 Jun; 105():618-629. PubMed ID: 26921769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Merck pushes the envelope with once-daily indinavir.
    TreatmentUpdate; 2001; 12(12):8. PubMed ID: 11570096
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicity.
    Boyd MA; Siangphoe U; Ruxrungtham K; Reiss P; Mahanontharit A; Lange JM; Phanuphak P; Cooper DA; Burger DM
    J Antimicrob Chemother; 2006 Jun; 57(6):1161-7. PubMed ID: 16595641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portal vein thrombosis in patients receiving indinavir, an HIV protease inhibitor.
    Carr A; Brown D; Cooper DA
    AIDS; 1997 Nov; 11(13):1657-8. PubMed ID: 9365776
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective activation of α7 nicotinic acetylcholine receptor by PHA-543613 improves Aβ25-35-mediated cognitive deficits in mice.
    Sadigh-Eteghad S; Talebi M; Mahmoudi J; Babri S; Shanehbandi D
    Neuroscience; 2015 Jul; 298():81-93. PubMed ID: 25881725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.